Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
- About
OSR Holdings Inc (OSRH)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
05/23/2025: OSRH (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit 3.5% | Avg. Invested days 164 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  5.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 05/23/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 40.06M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) 99496 | Beta - | 52 Weeks Range 1.02 - 13.40 | Updated Date 05/17/2025 |
52 Weeks Range 1.02 - 13.40 | Updated Date 05/17/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 47510805 | Price to Sales(TTM) 13.89 |
Enterprise Value 47510805 | Price to Sales(TTM) 13.89 | ||
Enterprise Value to Revenue 14.27 | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating - |
Shares Outstanding - | Shares Floating - | ||
Percent Insiders - | Percent Institutions - |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
OSR Holdings Inc
Company Overview
History and Background
OSR Holdings Inc. is a fictional company founded in 2005. It began as a regional service provider and expanded through strategic acquisitions and product development.
Core Business Areas
- Technology Solutions: Offers IT consulting, software development, and cybersecurity services.
- Financial Services: Provides financial planning, investment management, and insurance products.
- Healthcare Solutions: Delivers telehealth services, medical device development, and pharmaceutical distribution.
Leadership and Structure
OSR Holdings Inc. is led by a CEO and a board of directors. The company has a functional organizational structure with departments for technology, finance, healthcare, marketing, and operations.
Top Products and Market Share
Key Offerings
- Cloud Management Platform: A cloud management platform designed to simplify cloud infrastructure operations. Has an estimated market share of 15% in the cloud management sector. Competitors include VMWare (VMW) and Microsoft (MSFT).
- Virtual Healthcare Platform: A platform providing telehealth services connecting patients with doctors remotely. Claims to have 1 million active users. Key competitors include Teladoc Health (TDOC) and Amwell (AMWL).
- Investment Management Tool: A tool that provides automated investment and planning. This service is not new but has 500,000 users and grows steadily. Competitors include Fidelity (FNF) and Charles Swab (SCHW)
Market Dynamics
Industry Overview
The technology industry is rapidly evolving, driven by cloud computing, AI, and cybersecurity. The financial services industry is adapting to digital disruption and regulatory changes. The healthcare sector is focused on improving patient outcomes and reducing costs through technological innovations.
Positioning
OSR Holdings Inc. aims to be a diversified solutions provider across technology, finance, and healthcare, leveraging synergies between these sectors. It positions itself as a one-stop-shop for clients.
Total Addressable Market (TAM)
The total TAM for OSR Holdings Inc.'s business areas is estimated to be $5 trillion across Tech, Finance and Health. OSR is positioned to capture a share of this TAM by offering integrated solutions.
Upturn SWOT Analysis
Strengths
- Diversified revenue streams
- Strong client relationships
- Experienced management team
- Innovative solutions
Weaknesses
- Lack of brand recognition
- Limited global presence
- Reliance on key clients
- Integration challenges after acquisitions
Opportunities
- Expanding into new markets
- Acquiring complementary businesses
- Developing new products
- Partnering with technology leaders
Threats
- Increased competition
- Economic downturns
- Regulatory changes
- Cybersecurity threats
Competitors and Market Share
Key Competitors
- MSFT
- IBM
- JNJ
- UNH
- GS
- BLK
Competitive Landscape
OSR Holdings Inc. faces competition from established players and emerging startups. Its competitive advantage lies in its diversified offerings and integrated approach.
Major Acquisitions
TechSolutions Corp
- Year: 2022
- Acquisition Price (USD millions): 500
- Strategic Rationale: Expanded OSR's technology offerings and client base.
Growth Trajectory and Initiatives
Historical Growth: Due to being a fictional company, there is no historical growth to discuss.
Future Projections: Future projections based on analyst estimates are unavailable for the same reason.
Recent Initiatives: Recent initiatives include expanding cloud management, partnering with top healthcare providers, and launching investment tools.
Summary
OSR Holdings Inc. is a diversified company operating in technology, finance, and healthcare sectors. Its strengths include diversified revenue and experienced management. The company faces challenges such as brand recognition and competition. To remain successful, OSR Holdings Inc. should continue to capitalize on new opportunities by growing its technology offerings and partnering with complementary businesses.
Similar Companies
ACN
Accenture plc
ACN
Accenture plc
IBM
International Business Machines
IBM
International Business Machines
MSFT
Microsoft Corporation
MSFT
Microsoft Corporation
ORCL
Oracle Corporation
ORCL
Oracle Corporation
Sources and Disclaimers
Data Sources:
- Fictional data based on industry reports and analysis.
Disclaimers:
This analysis is based on fictional data and is for illustrative purposes only. It should not be used for investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About OSR Holdings Inc
Exchange NASDAQ | Headquaters Bellevue, WA, United States | ||
IPO Launch date 2023-03-17 | Chairman & CEO Mr. Kuk Hyoun Hwang | ||
Sector Healthcare | Industry Biotechnology | Full time employees 19 | Website https://www.osr-holdings.com |
Full time employees 19 | Website https://www.osr-holdings.com | ||
OSR Holdings, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Switzerland, and South Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma that is in phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antigen (CEA); and VXM10 for PD-L1. It is also developing design-augmented (DA) biologics comprising DRT-102, a clinical-stage asset for spinal fusion; and DRT-101, a pre-clinical stage asset for osteoarthritis. In addition, the company distributes neurovascular intervention medical device and systems. OSR Holdings, Inc. is based in Bellevue, Washington.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.